Northeast Financial Consultants’s Inspire Medical Systems INSP Stock Holding History

Northeast Financial Consultants’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,300	Closed	-$207K	–	303
2025 Q1	$207K	Hold	1,300	–	–	0.01%	270
2024 Q4	$241K	Hold	1,300	–	–	0.01%	264
2024 Q3	$274K	Buy	+1,300	New	+$226K	0.01%	243
2024 Q2	–	Sell	-1,300	Closed	-$279K	–	284
2024 Q1	$279K	Hold	1,300	–	–	0.01%	246
2023 Q4	$264K	Hold	1,300	–	–	0.01%	239
2023 Q3	$258K	Hold	1,300	–	–	0.02%	235
2023 Q2	$422K	Hold	1,300	–	–	0.03%	200
2023 Q1	$304K	Hold	1,300	–	–	0.02%	247
2022 Q4	$327K	Hold	1,300	–	–	0.02%	230
2022 Q3	$231K	Hold	1,300	–	–	0.02%	293
2022 Q2	$237K	Hold	1,300	–	–	0.02%	289
2022 Q1	$334K	Hold	1,300	–	–	0.02%	286
2021 Q4	$299K	Hold	1,300	–	–	0.02%	280
2021 Q3	$303K	Hold	1,300	–	–	0.02%	285
2021 Q2	$251K	Hold	1,300	–	–	0.02%	309
2021 Q1	$269K	Hold	1,300	–	–	0.02%	283
2020 Q4	$245K	Buy	+1,300	New	+$213K	0.02%	287

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DIG

Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Northeast Financial Consultants's INSP Position: Q2 2025 in Review

Northeast Financial Consultants sold out of Inspire Medical Systems (INSP) in Q2 2025, closing a stake of 1,300 shares — an estimated $207K sold.

Northeast Financial Consultants first reported a position in INSP in Q4 2020 and held it in 17 quarters. The position peaked at $422K in Q2 2023. 356 funds tracked by Wall St. Rank hold INSP as of Q2 2025.

Northeast Financial Consultants reported no remaining Inspire Medical Systems position as of Q2 2025 after selling out during the quarter.
Northeast Financial Consultants sold 1,300 Inspire Medical Systems shares in Q2 2025, an estimated $207K.
Northeast Financial Consultants first reported a position in Inspire Medical Systems in Q4 2020 and held it in 17 quarters.
Northeast Financial Consultants's Inspire Medical Systems position peaked at $422K in Q2 2023.
356 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2025.

Based on Northeast Financial Consultants's 13F filing for Q2 2025, filed 15 Aug 2025.